Science Explorer Back to mapMap
Discussion
Researcher · 3M (United States) · United States

Mark A. Tomai

Mark A. Tomai publishes mostly in Immunology, Infectious Diseases and Epidemiology, on topics such as Immunotherapy and Immune Responses, Immune Response and Inflammation and Immune Cell Function and Interaction.

ORCID 0000-0002-6362-9151 OpenAlex
World rank
#149,723
of 7,710,434 ranked researchers
Rank in United States
#56,450
of 1,627,098
Works
129
Citations
8.7k
Citations per work
67.5
h-index
51
i10-index 89Top 4% in Immunology
Mark A. Tomai

What does Mark A. Tomai research?

Mark A. Tomai's work is mostly in Immunology and Microbiology (51%), Medicine (20%), Biochemistry, Genetics and Molecular Biology (5%).

Life Sciences: 72 works · 55.6% of their workImmunology and Microbiology: 65 works · 50.7% of their workImmunology: 54 works · 41.9% of their workVirology: 6 works · 4.7% of their workMicrobiology: 5 works · 4.1% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 4.9% of their workMolecular Biology: 6 works · 4.9% of their workEverything else: 31 works · 24.1% of their workHealth Sciences: 26 works · 20.3% of their workMedicine: 26 works · 20.3% of their workInfectious Diseases: 14 works · 10.7% of their workEpidemiology: 12 works · 9.6% of their workTHEIR WORKMark A. Tomai129works
Life Sciences56%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology6550.7%
    2. Biochemistry, Genetics and Molecular Biology64.9%
  2. Everything else3124.1%
    1. Medicine2620.3%
  1. 1Immunology42% of their works
  2. 2Infectious Diseases11% of their works
  3. 3Epidemiology10% of their works
  4. 4Molecular Biology5% of their works
  5. 5Virology5% of their works
  6. 6Microbiology4% of their works

Research topics

Which keywords describe Mark A. Tomai's research?

The keywords of their largest research topics: Immunity, Antigen Presentation, Cancer Immunotherapy, Dendritic Cells, Pattern Recognition Receptors, Toll-like Receptors, Vaccine and Natural Killer Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Immunity632 topics
  2. Antigen Presentation512 topics
  3. Cancer Immunotherapy441 topic
  4. Dendritic Cells441 topic
  5. Pattern Recognition Receptors421 topic
  6. Toll-like Receptors421 topic
  7. Vaccine362 topics
  8. NK Cell Recognition271 topic
  9. Natural Killer Cells271 topic
  10. Coronavirus191 topic
  11. SARS-CoV-2191 topic
  12. AIDS171 topic
  13. Foxp3171 topic
  14. HIV171 topic
  15. TGF-ß171 topic
  16. Decidual NK Cells81 topic
  17. Regulatory T Cells81 topic
  18. Epitope Prediction71 topic
  19. Peptide-MHC Binding71 topic

Where does Mark A. Tomai work?

Mark A. Tomai's main affiliation in the publication record is 3M (United States), United States.

How many publications and citations does Mark A. Tomai have?

OpenAlex counts 129 works and 8,704 citations for Mark A. Tomai, an h-index of 51, ranking #149,723 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark A. Tomai. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.